Charles Bonnet syndrome

Optometry

Volumn 82, Issue 7, 2011, Pages 421-427

  Yacoub, Robert ^a   Ferrucci, Steven ^a,b  

^a SOUTHERN CALIFORNIA COLLEGE OF OPTOMETRY   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Charles bonnet syndrome; Visual hallucinations; Visual impairment

Indexed keywords

AGED; ARTICLE; CASE REPORT; DIABETIC RETINOPATHY; DIFFERENTIAL DIAGNOSIS; HALLUCINATION; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RETINA MACULA DEGENERATION; SYNDROME;

AGED; AGED, 80 AND OVER; DIABETIC RETINOPATHY; DIAGNOSIS, DIFFERENTIAL; HALLUCINATIONS; HUMANS; MACULAR DEGENERATION; MAGNETIC RESONANCE IMAGING; MALE; SYNDROME;

EID: 79959334264     PISSN: 15291839     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.optm.2010.11.014     Document Type: Article

References (32)

1. Menon G.J., Rahman I., Menon S.J., et al. Complex visual hallucinations in the visually impaired: The Charles Bonnet syndrome. Surv Ophthalmol 2003, 48(1):58-71.
2. Kester E.M. Charles Bonnet syndrome: Case presentation and literature review. Optometry 2009, 80(7):360-366.
3. Vukicevic M., Fitzmaurice K. Butterflies and black lacy patterns: the prevalence and characteristics of Charles Bonnet hallucinations in an Australian population. Clin Exp Ophthalmol 2008, 36(7):659-665.
4. Rovner B. The Charles Bonnet syndrome-Visual hallucinations caused by visual impairment. Geriatrics 2002, 57(6):45-46.
5. Cole M. Charles Bonnet syndrome: an example of cortical dissociation syndrome affecting vision?. J Neuro Neurosurg Psychiatry 2001, 71:134.
6. Jacob A., Prasad S., Bogglid M., et al. Charles Bonnet syndrome-elderly people and visual hallucinations. Br J Ophthalmol 2004, 328:1552-1554.
7. Tran C., Eong K. Charles Bonnet syndrome: hallucinations may not be what they seem. Clin Exp Optom 2004, 87:405-406.
8. Skorin L. Disorder has patients " seeing things" Rev Optometry 2005, 142:49-55.
9. Vision loss and visual hallucinations: The Charles Bonnet syndrome. Insight 2009, 34(4):41.
10. Tan C.S.H., Lim V.S.Y., Ho D.Y.M., et al. Charles Bonnet syndrome in Asian patients in a tertiary ophthalmic centre. British J Ophthalmol 2004, 88:1325-1329.
11. Schadlu A.P., Schadlu R., Shepherd J.B. Charles Bonnet syndrome: A review. Curr Opin Ophthalmol 2009, 20(3):219-222.
12. Gilmour G., Schreiber C., Ewing C. An examination of the relationship between low vision and Charles Bonnet syndrome. Can J Ophthalmol 2009, 44(1):49-52.
13. Pankow L., Luchins D. An optical intervention for visual hallucinations associated with visual impairment in an elderly patient. Optom Vis Sci 1997, 74:138-143.
14. Manford M., Anderman F. Complex visual hallucinations: Clinical and neurobiological insights. Brain 1998, 121:1819-1840.
15. Abbott E.J., Connor G.B., Artes P.H., et al. Visual loss and visual hallucinations in patients with age-related macular degeneration (Charles Bonnet syndrome). Invest Ophthalmol Vis Sci 2007, 48(3):1416-1423.
16. Crumbliss K.E., Taussig M.J., Jay W.M. Vision rehabilitation and Charles Bonnet syndrome. Semin Ophthalmol 2008, 23(3):121-126.
17. Rovner B.W. The Charles Bonnet syndrome: a review of recent research. Curr Opin Ophthalmol 2006, 17(3):275-277.
18. Burke W. The neural basis of Charles Bonnet hallucinations: a hypothesis. J Neuro Neurosurg Psychiatry 2002, 73:535-554.
19. Madill S.A., Lascaratos G., Arden G.B., et al. Perceived color of hallucinations in the Charles Bonnet syndrome is related to residual color contrast sensitivity. J Neuro-Ophthalmol 2009, 29(3):192-196.
20. Pula JH, Reder AT. Multiple sclerosis. Part I: Neuro-ophthalmic manifestations. Curr Opin Ophthalmol 20(6):467-75.
21. Reimer J., Aderhold V., Lambert M., et al. Manifestations of multiple sclerosis with paranoid-hallucinatory psychosis. J Neurol 2006, 253:531-532.
22. Hubbard J., Levenson J., Patrick G. Psychiatric side effects associated with the ten most commonly dispensed prescription drugs: a review. J Family Pract 1983, 33(2):177-186.
23. Tan C.S., Sabel B.A. Dynamic changes in visual acuity as the pathophysiologic mechanism in Charles Bonnet syndrome. Eur Arch Psychiatry Clin Neurosci 2006, 256:62-63.
24. Kazui H., Ishii R., Yoshida T., et al. Neuroimaging studies in patients with Charles Bonnet syndrome. Psychogeriatrics 2009, 9(2):77-84.
25. Santhouse A.M., Howard R.J., Ffytche D.H. Visual hallucinatory syndromes and the anatomy of the visual brain. Brain 2000, 123:2055-2064.
26. Terao T. Hallucinations in Alzheimer's disease and Charles Bonnet syndrome. Am J Psychol 2000, 157:2062.
27. Tomsak R.L., Zaret C.R., Weidenthal D. Charles Bonnet syndrome precipitated by brimonidine tartrate eye drops. Br J Ophthalmol 2003, 87:917.
28. Rashman I., Fernando B., Harrison M. Charles Bonnet syndrome and brimonidine: comments. Br J Ophthalmol 2004, 88:724.
29. Cohen S.Y., Bulik A., Tadayoni R., et al. Visual hallucinations and Charles Bonnet syndrome after photodynamic therapy for age related macular degeneration. Br J Ophthalmol 2003, 87:977-979.
30. Schultz G., Needham W., Taylor R., et al. Properties of complex hallucinations associated with deficits in vision. Perception 1996, 25:715.
31. Eperjesi F., Akbarali N. Rehabilitation in Charles Bonnet syndrome: a review of treatment options. Clin Exp Optom 2004, 87:149-152.
32. Murphy J. By 2030, ranks of blind to double. Rev Optom 2002, 139:4.